Vimarsana
Biggest News Aggregation in the World

Page 9 - Solutions Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Solutions Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Solutions Segment Today - Breaking & Trending Today

Digital China (OTCMKTS:DCHIF) Sets New 12-Month High at $0.48 - Vimarsana News

Digital China (OTCMKTS:DCHIF) Sets New 12-Month High at $0.48

Volume of 2000 shares traded. The stock price of Digital China Holdings Limited reached a new 52-week high during trading on Wednesday.

Daseke Reports Results for First-Quarter 2023 and Updates 2023 Outlook - Vimarsana News

Daseke Reports Results for First-Quarter 2023 and Updates 2023 Outlook

Executed asset-right strategy, generated 4.1% growth in company loads and improved utilizationReduced $50 million of total debt and redeemed $20 million of preferred shares, improving financial... | May 9, 2023

Stevanato Group Reports First Quarter 2023 Financial Results - Vimarsana News

Stevanato Group Reports First Quarter 2023 Financial Results

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology

Stevanato Group S.p.A.: Stevanato Group Reports First Quarter 2023 Financial Results - Vimarsana News

Stevanato Group S.p.A.: Stevanato Group Reports First Quarter 2023 Financial Results

- Reiterates Full Year 2023 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology

Parsons Reports Strong First Quarter 2023 Results - Vimarsana News

Parsons Reports Strong First Quarter 2023 Results

Q1 2023 Financial Highlights Record quarterly revenue of $1.2 billion, representing a 24% increase year-over-yearRecord quarterly organic revenue growth of 12% driven by strength in both... | May 3, 2023